Previous Close | 58.92 |
1-Year Change | 2.38% |
6-Months Change | -1.83% |
3-Months Change | 6.64% |
Moving Avg (50d) | 57.052 |
Moving Avg (200d) | 60.047 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.11B |
Beta (3-Years) | 0.82 |
Revenue Growth (ttm) | 58.75% |
Net Profit Margin (ttm) | 2.98% |
Return On Assets (ttm) | 1.5% |
EPS (ttm) | 0.51 |
PE Ratio (ttm) | 115.53 |
Dividend Yield | 0.15% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |